Your Partner for Gene Transfer

After the completion of the human genome project, the functional analysis of the genes identified and of their expression products have become one of the major tasks for the years to come. amaxa's innovative gene transfer technology will make a significant contribution to this endeavor.

amaxa offers a wide range of transfection products for primary cells and cell lines suitable for DNA, RNA and  siRNA transfer. amaxa's Nucleofector technology is ideally suited to boost functional genomics and proteomics research and eventually therapy development. Furthermore, amaxa's Nucleofector technology is an ideal ex-vivo tool for gene-based medicine. Technologies under development will also be suitable for in-vivo gene transfer.

amaxa is constantly looking for partners in the pharmaceutical and biotech industry to leverage the strengths of its technology platform and to develop new applications.